Reasons to Believe In S-ICD

Reasons to Believe In S-ICD

Believe in the data

Electrophysiology / Reasons to Believe in S-ICD

 

Believe in the data

 

ATLAS randomised controlled trial shows S-ICD is superior to TV-ICD in serious lead-related complication rates*1.

Newly published article:

What the ATLAS superiority results mean for S-ICD therapy

This review, by Dr Rordorf, discusses key clinical evidence comparing S-ICD and TV-ICD in order to help inform physician´s patient selections for S-ICDs. Dr Rordorf highlights latest data from the ATLAS randomized clinical trial which point to exciting opportunities for patients who are at risk of sudden cardiac death.
Read the article here
Reasons to believe in S-ICD
 
S-ICD consistently shows high long-term shock efficacy, while data from the ATLAS and PRAETORIAN randomised controlled trials demonstrate S-ICD is superior to TV-ICD in preventing the serious complications associated with invasive leads as early as 6 months after implant in adults of all ages with the most common ICD indications.*1,4
S-ICD Conversion Rate
sicd-vector
Reduction in serious lead-related complications
sicd-vector
 
Reasons to believe in S-ICD

Your reason to believe in S-ICD - with Professor Pier Lambiase.

Professor Lambiase talks us through the key findings from landmark clinical trials - EFFORTLESS, UNTOUCHED and PRAETORIAN. He discusses:- Reducing Inappropriate Shocks- Lead complications- Safety and efficacy of S-ICD.

 
SICS RTB BANNER

 

Our Webinar Series

 
What we’ve learned
from 100,000 S-ICD patients
On-demand webinar screenshot.
Our first webinar recording, with Dr. Knops and Professor Lambiase reviewed clinical datacoming from trials like PRAETORIAN which further strengthens and supports why S-ICD should be considered for a more diverse patient population.
ATLAS and the
Weight of Experience
On-demand webinar screenshot.
Our second webinar recording where Dr. Healey discussed the results of the ATLAS trial, evaluating and comparing the lead-related complications between TV-ICD and S-ICD, and reviewing key secondary endpoints including inappropriate shocks.
 
S-ICD in Real Life -
The French Touch
Our latest webinar recording, with Prof. Marijon and Prof. Lambiase, reviewed data from the French Cohort Study (HONEST) and the real-world experience with S-ICD. This study provides data from a nationwide cohort evaluating the performance of the S-ICD in France.
On-demand webinar screenshot.

 

From a patient's perspective

 
Your reason to believe in S-ICD - from a patient's perspective.

Your reason to believe in S-ICD - from a patient´s perspective.

With more than 100,000* patients protected by having an      S-ICD we would like you to listen to a few who wish to share their story with you. Javier, Sarina and Vanessa share why they were implanted with an S-ICD and their feelings about their device.

 
Top